Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study-Reference-Cited by-同舟云学术

Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study

Published:2017-02 Issue:1 Volume:9 Page:103-109
ISSN:1757-7853
Container-title:Orthopaedic Surgery
language:en
Short-container-title:Orthop Surg

Author:

Liang Bo-cheng¹²,Shi Zhen-yu¹,Wang Bo¹,Wu Peng¹,Kong Ling-cheng¹,Yao Jian-liang¹,Li Chun-wen³,Shi Xiao-lin²

Affiliation:

1. Department of Osteology; Second Clinical Medical College, Zhejiang Chinese Medical University; Hangzhou China

2. Department of Osteology; The Second Affiliated Hospital of Zhejiang Chinese Medical University; Hangzhou China

3. Department of Diagnostics of Traditional Chinese Medicine; College of Basic Medical Science, Zhejiang Chinese Medical University; Hangzhou China

Funder

Novartis Pharma

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/os.12307/fullpdf

Reference30 articles.

1. European guidance for the diagnosis and management of osteoporosis in postmenopausal women;Kanis;Osteoporos Int,2013

2. Projection of incidence and economic burden of osteoporosis-related fractures in China: 2010-2050;Si;Osteoporos Int,2015

3. Spinal trauma in mainland China from 2001 to 2007: an epidemiological study based on a nationwide database;Liu;Spine (Phila Pa 1976),2012

4. Rapidly increasing rates of hip fracture in Beijing, China;Xia;J Bone Miner Res,2012

5. Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis;Ganda;Osteoporos Int,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of zoledronic acid in combination with calcium tablets and calcitriol for hip biomechanics and bone mineral density after total hip replacement: a prospective randomized controlled trial;2024-04-08

2. Bisphosphonate alternative regimens for the prevention of osteoporotic fragility fractures: BLAST-OFF, a mixed-methods study;HEALTH TECHNOL ASSES;2024

3. Optimization of the dosage regimen of zoledronic acid with a kinetic-pharmacodynamic model and exposure-response analysis;Frontiers in Pharmacology;2023-09-27

4. Effects of Bazedoxifene/Vitamin D Combination Therapy on Serum Vitamin D Levels and Bone Turnover Markers in Postmenopausal Women with Osteopenia: A Randomized Controlled Trial;Journal of Bone Metabolism;2023-05-31

5. Drug efficacy and safety of denosumab, teriparatide, zoledronic acid, and ibandronic acid for the treatment of postmenopausal osteoporosis: a network meta-analysis of randomized controlled trials;EUR REV MED PHARMACO;2023